Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial

[1]  J. Overgaard,et al.  OC-0371: Hypo- vs normofractionated radiation of early breast cancer in the randomized DBCG HYPO trial , 2020, Radiotherapy and Oncology.

[2]  Do-Hoon Kim,et al.  External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial , 2019, The Lancet.

[3]  W. Curran,et al.  Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial , 2019, The Lancet.

[4]  Chen Hu,et al.  Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial. , 2019, The Lancet. Oncology.

[5]  J. Yarnold,et al.  FAST Phase III RCT of Radiotherapy Hypofractionation for Treatment of Early Breast Cancer: 10-Year Results (CRUKE/04/015) , 2018, International Journal of Radiation Oncology, Biology, Physics.

[6]  Susan Todd,et al.  Recommendations on multiple testing adjustment in multi-arm trials with a shared control group , 2018, Statistical methods in medical research.

[7]  Jean L Wright,et al.  Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline. , 2018, Practical radiation oncology.

[8]  I. Ellis,et al.  Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial , 2017, The Lancet.

[9]  P. Evans,et al.  The UK HeartSpare Study (Stage II): Multicentre Evaluation of a Voluntary Breath-hold Technique in Patients Receiving Breast Radiotherapy. , 2017, Clinical oncology (Royal College of Radiologists (Great Britain)).

[10]  R. Pötter,et al.  Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial , 2017, The Lancet. Oncology.

[11]  J. Yarnold,et al.  Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  M. Krause,et al.  OC-0142: Hypo- vs normofractionated radiation of early breast cancer in the randomised DBCG HYPO trial , 2016 .

[13]  R. Peto,et al.  Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials , 2014, The Lancet.

[14]  Joanne S Haviland,et al.  The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. , 2013, The Lancet. Oncology.

[15]  Philip M Evans,et al.  The UK HeartSpare Study: randomised evaluation of voluntary deep-inspiratory breath-hold in women undergoing breast radiotherapy. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  A. Bottomley,et al.  Development of an EORTC quality of life phase III module measuring cancer‐related fatigue (EORTC QLQ‐FA13) , 2013, Psycho-oncology.

[17]  P. Hall,et al.  Risk of ischemic heart disease in women after radiotherapy for breast cancer. , 2013, The New England journal of medicine.

[18]  R Peto,et al.  Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials , 2011, The Lancet.

[19]  G. Bonsel,et al.  Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) , 2011, Quality of Life Research.

[20]  Joanne S Haviland,et al.  First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015). , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[21]  Anthony Fyles,et al.  Long-term results of hypofractionated radiation therapy for breast cancer. , 2010, The New England journal of medicine.

[22]  J. Yarnold,et al.  Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials. , 2010, The Lancet. Oncology.

[23]  M. Bollet,et al.  Breast-conserving treatment in the elderly: long-term results of adjuvant hypofractionated and normofractionated radiotherapy. , 2009, International journal of radiation oncology, biology, physics.

[24]  P. Lambin,et al.  Responsiveness of the EQ-5D in breast cancer patients in their first year after treatment , 2009, Health and quality of life outcomes.

[25]  D. Tait,et al.  Evaluation of a method for grading late photographic change in breast appearance after radiotherapy for early breast cancer. , 2008, Clinical oncology (Royal College of Radiologists (Great Britain)).

[26]  D. Tait,et al.  Acute toxicity and 2-year adverse effects of 30 Gy in five fractions over 15 days to whole breast after local excision of early breast cancer. , 2008, Clinical oncology (Royal College of Radiologists (Great Britain)).

[27]  M. Jeffery,et al.  Fraction size in radiation treatment for breast conservation in early breast cancer. , 2008, The Cochrane database of systematic reviews.

[28]  J. Yarnold,et al.  The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial , 2008, The Lancet. Oncology.

[29]  H. Bartelink,et al.  Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  M. Aalabaf-Sabaghi.  Decision modelling for health economic evaluation , 2007, Journal of Epidemiology and Community Health.

[31]  John R Yarnold,et al.  Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. , 2006, The Lancet. Oncology.

[32]  A. Courdi,et al.  Long-term results of hypofractionated radiotherapy and hormonal therapy without surgery for breast cancer in elderly patients. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[33]  T. Michalska,et al.  Radiation-induced brachial plexopathy and hypofractionated regimens in adjuvant irradiation of patients with breast cancer-a review , 2006, Acta oncologica.

[34]  Roger Owen,et al.  Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[35]  J. Hanley,et al.  Statistical analysis of correlated data using generalized estimating equations: an orientation. , 2003, American journal of epidemiology.

[36]  Lisa Barbera,et al.  Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  T. Whelan,et al.  Randomized Trial of Breast Irradiation Schedules After Lumpectomy for Women With Lymph Node-Negative Breast Cancer , 2002 .

[38]  C. Freeman,et al.  Delay in adjuvant radiation treatment and outcomes of breast cancer – a review , 2002, Breast Cancer Research and Treatment.

[39]  P. Hoskin,et al.  A survey of radiotherapy quality control practice in the United Kingdom for the START trial. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[40]  D G Altman,et al.  Calculating the number needed to treat for trials where the outcome is time to an event , 1999, BMJ.

[41]  S M Bentzen,et al.  Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[42]  N. Aaronson,et al.  The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  S. Dische,et al.  Quality assurance in the CHART clinical trial. , 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[44]  H. Bartelink,et al.  EORTC guidelines for writing protocols for clinical trials of radiotherapy. , 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[45]  H. Bartelink,et al.  The programme of quality assurance of the EORTC radiotherapy group. A historical overview. , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[46]  D. Osoba,et al.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.

[47]  A Agresti,et al.  A survey of models for repeated ordered categorical response data. , 1989, Statistics in medicine.

[48]  T. Bates.  The 10-year results of a prospective trial of post-operative radiotherapy delivered in 3 fractions per week versus 2 fractions per week in breast carcinoma. , 1988, The British journal of radiology.

[49]  J. Yarnold,et al.  Local relapse rates are falling after breast conserving surgery and systemic therapy for early breast cancer: can radiotherapy ever be safely withheld? , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[50]  R. Fitzpatrick,et al.  A STRUCTURED REVIEW OF PATIENT-REPORTED OUTCOME MEASURES (PROMs) FOR BREAST CANCER , 2009 .

[51]  Surgical guidelines for the management of breast cancer. , 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[52]  A. Bottomley,et al.  Development of an EORTC module for the assessment of cancer related fatigue (EORTC FAR-15): Phase III results. , 2007 .

[53]  C. Sugar,et al.  Putting the 'Q' in quality adjusted life years (QALYs) for advanced ovarian cancer - An approach using data clustering methods and the internet. , 2007, European journal of cancer.

[54]  Penny Hopwood,et al.  A body image scale for use with cancer patients. , 2001, European journal of cancer.

[55]  F. Vicini,et al.  Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer. , 1992, International journal of radiation oncology, biology, physics.

[56]  I. Turesson,et al.  Accelerated versus conventional fractionation. The degree of incomplete repair in human skin with a four-hour-fraction interval studied after postmastectomy irradiation. , 1988, Acta oncologica.

[57]  C. Chant,et al.  Early and locally Advanced Breast cancer , 2022 .